Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
This NOFO funds early-stage bioengineering projects (R21) to establish feasibility and potential utility of new tools, methods, or technologies that advance biomedical research, clinical care, or accessibility. It supports high-risk, multidisciplinary, minimally preliminary-data studies (clinical trial optional) with direct costs capped at $275,000 across two years. Phase III clinical trials a…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
National Institutes of Health
-
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
National Institutes of Health
-
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
National Institutes of Health ▸ National Institute of Biomedical Imaging and Bioengineering
-
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
National Institutes of Health ▸ National Institute of Neurological Disorders and Stroke
-
Engineering of Biomedical Systems
National Science Foundation
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers